Rigel Pharmaceuticals Inc (RIGL)

Stock-Based Compensation

$16.41M

TTM · Period ending: · USD

RIGL logo

RIGL Stock-Based Compensation

Latest reported$16.41M
RIGL TTM Stock-Based Comp ($3.72M → $16.41M)
High-resolution chart · PNG

RIGL stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rigel Pharmaceuticals Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
16,411,000
12,843,000
12,711,000
12,050,000
11,331,000
10,583,000
12,393,000
12,239,000
11,538,000
11,182,000
8,806,000
10,953,000
11,717,000
11,936,000
12,385,000
10,644,000
10,139,000
10,054,000
9,486,000
8,779,000
8,461,000
7,912,000
7,297,000
7,076,000
7,290,000
8,186,000
9,115,000
9,761,000
10,658,000
9,117,000
7,704,000
8,706,000
6,584,000
6,572,000
5,987,000
5,594,000
5,936,000
6,850,000
7,333,000
6,292,000
6,892,000
6,787,000
7,403,000
8,989,000
9,254,000
9,477,000
9,787,000
8,139,000
8,122,000
7,737,000
7,166,000
8,866,000
10,048,000
11,312,000
12,617,000
12,395,000
12,240,000
12,429,000
13,168,000
13,928,000
14,605,000
15,106,000
16,436,000
16,416,000
16,181,000
16,339,000
13,438,000
9,657,000
6,125,000
2,266,000
5,846,000
5,846,000
5,846,000
5,846,000
2,622,000
15,201,000
15,201,000
15,201,000
16,140,000
3,591,000
3,591,000
3,591,000
36,000
133,000
133,000
-677,000
-629,000
-756,000
-756,000
-236,000
-66,000
-66,000
-66,000
224,000
480,000
3,113,000
3,113,000
3,113,000
3,722,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.